Article info
Original Article
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
- Correspondence to N Colombo, ESMO Guidelines Committee, ESMO Head Office, Lugano 6900, Switzerland; clinicalguidelines{at}esmo.org; D Querleu, ESGO Guidelines Committee, ESGO Office, Prague 110 00, Czech Republic; esgo-guidelines{at}esgomail.org
Citation
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Publication history
- Received January 25, 2019
- Accepted February 25, 2019
- First published May 2, 2019.
Article Versions
- You are currently viewing a Previous version of this article (7 May 2019).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© The Authors 2019. No commercial re-use. See rights and permissions. Published by BMJ.